Medindia2m
Novartis receives third FDA approval for oral Fabhalta (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)
Fabhalta is the only oral inhibitor of the alternative complement pathway to selectively target what is thought to be the underlying cause of the disease1-3. Before the approval ... of twice-daily ...
Doctor busts egg-cholesterol myth, says he eats 28 eggs per week
Dr. Deep Dutta, an endocrinologist, countered the myth that eggs raise cholesterol, stating his own experience eating 28 eggs ...